Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. … Read More

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

[ad_1] Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket … Read More

The pet drugs vets are now prescribing look a lot more like human medications

[ad_1] Monty Rakusen | Digitalvision | Getty Images If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don’t need to … Read More

Highmark Health says it’s combining tech from Google and Epic to give doctors easier access to information

[ad_1] Google Cloud CEO Thomas Kurian speaks at the Google Cloud Next event in San Francisco, April 9, 2019. Michael Short | Bloomberg | Getty Images Highmark Health announced Monday … Read More

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

[ad_1] The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmingly affects Black people and people … Read More

Jim Cramer says buy this data center equipment firm despite its weak guidance

[ad_1] Vertiv Holdings : The data center equipment maker, whose shares have roughly quadrupled over the past year, issued guidance that didn’t live up to Wall Street’s lofty expectations. However, … Read More

Most employer health plans don’t cover new blockbuster weight loss drugs, but that’s going to change

[ad_1] Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight loss. Despite the hefty price tag — typically between … Read More